| Literature DB >> 22331460 |
Donna P Frazier1, Robert D Kendig, Fumitake Kai, Dejan Maglic, Takayuki Sugiyama, Rachel L Morgan, Elizabeth A Fry, Sarah J Lagedrost, Guangchao Sui, Kazushi Inoue.
Abstract
The transcription factor Dmp1 is a Ras/HER2-activated haplo-insufficient tumor suppressor that activates the Arf/p53 pathway of cell-cycle arrest. Recent evidence suggests that Dmp1 may activate p53 independently of Arf in certain cell types. Here, we report findings supporting this concept with the definition of an Arf-independent function for Dmp1 in tumor suppression. We found that Dmp1 and p53 can interact directly in mammalian cells via the carboxyl-terminus of p53 and the DNA-binding domain of Dmp1. Expression of Dmp1 antagonized ubiquitination of p53 by Mdm2 and promoted nuclear localization of p53. Dmp1-p53 binding significantly increased the level of p53, independent of the DNA-binding activity of Dmp1. Mechanistically, p53 target genes were activated synergistically by the coexpression of Dmp1 and p53 in p53(-/-);Arf(-/-) cells, and genotoxic responses of these genes were hampered more dramatically in Dmp1(-/-) and p53(-/-) cells than in Arf(-/-) cells. Together, our findings identify a robust new mechanism of p53 activation mediated by direct physical interaction between Dmp1 and p53. ©2012 AACR.Entities:
Mesh:
Substances:
Year: 2012 PMID: 22331460 PMCID: PMC3319807 DOI: 10.1158/0008-5472.CAN-11-2410
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701